Serious adverse events associated with Bacille Calmette-Guérin vaccine in Canada

Pediatric Infectious Disease Journal

Volumn 24, Issue 6, 2005, Pages 538-541

  Deeks, Shelley L ^a   Clark, Michael ^c,f   Scheifele, David W ^d   Law, Barbara J ^e   Dawar, Meenakshi ^c   Ahmadipour, Nooshin ^a   Walop, Wikke ^a   Ellis, C Edward ^b   King, Arlene ^a  

^a Immunization and Respiratory Infections Division   (Canada)

^b PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^c HEALTH CANADA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e Winnepeg Children's Hospital   (Canada)

^f UNIVERSITY OF OTTAWA   (Canada)

Author keywords

Aboriginal people; Bacille Calmette Gu rin vaccine; Disseminated Bacille Calmette Gu rin; Tuberculosis

Indexed keywords

BCG VACCINE;

ABORIGINE; CANADA; CELLULITIS; CHILD; DISEASE SEVERITY; DRUG FATALITY; DRUG INDUCED DISEASE; DRUG SURVEILLANCE PROGRAM; FEMALE; FEVER; HEALTH PROGRAM; HEALTH SURVEY; HOSPITAL ADMISSION; HUMAN; IMMUNE DEFICIENCY; IRRITABILITY; LYMPHADENITIS; LYMPHADENOPATHY; MAJOR CLINICAL STUDY; MALE; MILIARY TUBERCULOSIS; OSTEOMYELITIS; PRIORITY JOURNAL; REVIEW; SEIZURE; SKIN ABSCESS; SUPERINFECTION; WHEEZING;

ADVERSE DRUG REACTION REPORTING SYSTEMS; BCG VACCINE; CANADA; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; INDIANS, NORTH AMERICAN; INFANT; INFANT, NEWBORN; MALE; MYCOBACTERIUM BOVIS; OSTEOMYELITIS; TUBERCULOSIS;

EID: 20544468238     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000164769.22033.2c     Document Type: Review

References (21)

1. Elwood K. Bacille Calmette-Guérin vaccination. In: Long R, ed. Canadian Tuberculosis Standards. 5th ed. Ottawa, Canada: Canadian Lung Association; 2000:223-228.
2. Colditz GA, Berkey CS, Mosteller F, et al. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature. Pediatrics. 1995;96:29-35.
3. Rodrigues LC, Diwan VK, Wheeler JG. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol. 1993;22:1154-1158.
4. National Advisory Committee on Immunization. Statement on Bacille-Calmette Guérin (BCG) vaccine. Can Commun Dis Rep. 2004; 30(ACS-5):1-12.
5. Lotte A, Wasz-Hockert O, Poisson N, et al. Second IUATLD study on complications induced by intradermal BCG vaccination. Bull Int Union Tuberc Lung Dis. 1988;63:47-59.
6. Talbot EA, Perkins MD, Silva SFM, et al. Disseminated bacille Calmette-Guérin disease after vaccination: case report and review. Clin Infect Dis. 1997;24:1139-1146.
7. Lotte A, Wasz-Hockert O, Poisson N, et al. BCG complications: estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberc Res. 1984;21:107-193.
8. Gonzalez B, Moreno S, Burdach R, et al. Clinical presentation of Bacillus Calmette-Guérin infections in patients with immunodeficiency syndromes. Pediatr Infect Dis J. 1989;8:201-206.
9. Casanova JL, Jouanguy E, Lamhamedi S, et al. Immunological conditions of children with BCG disseminated infection. Lancet. 1995;346:581.
10. Health Canada. Tuberculosis in Canada, 2002: Cat. H49-108/2001. Ottawa, Canada: Minister of Public Works and Government Services; 2004.
11. Scheifele D, Law B, Jadavji T. Disseminated bacille Calmette- Guérin infection: three recent Canadian cases. IMPACT. Immunization Monitoring Program, Active. Can Commun Dis Rep. 1998;24:69-72.
12. Collet JP, MacDonald N, Cashman N, et al. Monitoring signals for vaccine safety: the assessment of individual adverse event reports by an expert advisory committee. Bull World Health Organ. 2000;78:178-185.
13. FitzGerald JM. Management of adverse reactions to Bacille Calmette-Guérin vaccine. Clin Inf Dis. 2000;31(suppl 3):S75-S6.
14. Houde C, Dery P. Mycobacterium bovis sepsis in an infant with human immunodeficiency virus infection. Pediatr Infect Dis J. 1988;7:810-812.
15. Dawar M, Clark M, Deeks SL, et al. A fresh look at an old vaccine: does BCG have a role in 21st century Canada? Int J Circum Health. 2004; 63:230-238.
16. Appelbaum FR. Bone marrow and stem cell transplantation. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison's Principles of Internal Medicine. 15th ed. Toronto, Canada: McGraw-Hill; 2001:739-744.
17. Dalai I, Reid B, Doyle J, et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant. 2000;25:613-621.
18. Hague RA, Rassam S, Morgan G, et al. Early diagnosis of severe combined immunodeficiency syndrome. Arch Dis Child. 1994;70:260-263.
19. Ferguson RG, Simes AB. BCG vaccination of Indian infants in Saskatchewan. Tubercle. 1949;30:5-11.
20. Frappier A, Frappier-Davignon L, Cantin M, et al. Influence de la vaccination par le BCG sur la mortalité par meningite tuberculeuse des enfants de 0 a 10 ans dans la Province de Québec. Can Med Assoc J. 1962;86:934-941.
21. Styblo K, Meijer J. Impact of BCG vaccination programmes in children and young adults on the tuberculosis problem. Tubercle. 1976;57:17-43.